Tuberc Respir Dis > Volume 37(3); 1990 > Article
Tuberculosis and Respiratory Diseases 1990;37(3):278-287.
DOI:    Published online September 1, 1990.
Drug Susceptibility Testing for Mycobacterium tuberculosis Using Microtiter Plate
Sang Jae Kim, Gill Han Bai, Sung Chan Yang
Korean Institute of Tuberculosis, Korean National Tuberculosis Association, Seoul, Korea
Microtiter Plate를 이용한 결핵균의 약제감수성 검사
김상재, 배길한, 양성찬
Use of microtiter plate to drug susceptibility testing for Mycobacterium tuberculosis has been evaluated in the hope of replacing it with the conventional method, which is so complex, laborious, and time.consuming that it requires more materials, equipments, and skilled technieque. The results obtained were summarized as follows. 1) Drug susceptibility testing with 240 isolates of M. tuberculosis using Löwenstein-Jensen medium showed 97.5% agreement of the results between two methods for kanamycin (KM) and rifampicin (RMP), 93.8% for streptomycin (SM), 92.9% for isoniazid (INH), 91.7% for p-aminosalicylic acid (PAS), and 89.6% for ethambut이 (EMB). In a separate study with 38 strains. using 10- 1 mg/ ml of inoculum, overall agreement was 100% for all drugs tested. 2) The direct susceptibility tests with 10 sputum specimens, that had been digested, decontaminated, concentrated by centrifugation, and then directly inoculated on the drug free and containing media, showed 100% agreement between two methods for EMB, ethionamide (TH), INH , RMP, SM, and tuberactionmycin (TUM), and 90% for CS, KM, and PAS. 3) Agreement was very poor between two tests for pyrazinamide (PZA), which had been done in acidic medium. Microtiter method is easy and rapid to perform and requires less amount of medium, merely one. tenth of the conventional method and no culture bottles or tubes. In addition, it is possible to shorten incubation period providing an average gain of 2 weeks or so. As the result of this study, microtiter method seems to be applicable for routine use except for PZA if the inoculum size and incubation period are well standardized.

Article category

Browse all articles >


Browse all articles >

Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail:                

Copyright © 2023 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next